Overview and historical perspective of four papers presented on research related to the endogenous opioid system

Drug and Alcohol Dependence

Volumn 108, Issue 3, 2010, Pages 195-199

  Kreek, Mary Jeanne ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; DYNORPHIN; ENKEPHALIN; MU OPIATE RECEPTOR; OPIATE RECEPTOR; PROOPIOMELANOCORTIN;

ALCOHOLISM; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANALGESIA; ENDOCYTOSIS; GENETIC VARIABILITY; HUMAN; MOLECULAR CLONING; NEUROBIOLOGY; NONHUMAN; NOTE; OPIATE ADDICTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; DISEASE MODELS, ANIMAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; OPIOID PEPTIDES; RECEPTORS, OPIOID, MU; SUBSTANCE-RELATED DISORDERS;

EID: 77952429924     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.03.003     Document Type: Note

References (28)

1. Bart G., Heilig M., LaForge K.S., Pollak L., Leal S.M., Ott J., Kreek M.J. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol. Psychiatry 2004, 9:547-549.
2. Bart G., Kreek M.J., Ott J., LaForge K.S., Proudnikov D., Pollak L., Heilig M. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 2005, 30:417-422.
3. Bergen A.W., Kokoszka J., Peterson R., Long J.C., Virkkunen M., Linnoila M., Goldman D. Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol. Psychiatry 1997, 2:490-494.
4. Berrettini W.H., Hoehe M.R., Ferrada T.N., Gottheil E. Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse. Addict. Biol. 1997, 2:303-308.
5. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., Borg L., Gong J., Schluger J., Strong J.A., Leal S.M., Tischfield J.A., Kreek M.J., Yu L. Single nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:9608-9613.
6. Corrigall W.A., Coen K.M. Opiate antagonists reduce cocaine but not nicotine self administration. Psychopharmacology (Berl.) 1991, 104:167-170.
7. Dole V.P., Nyswander M.E., Kreek M.J. Narcotic blockade. Arch. Intern. Med. 1966, 118:304-309.
8. Evans C.J., Keith D.E., Morrison H., Magendzo K., Edwards R.H. Cloning of a delta opioid receptor by functional expression. Science (Wash DC). 1992, 258:1952-1955.
9. Evans C.J., Walwyn W.M., Miiotto K.A. Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend. 2010, 108:156-165.
10. Goldstein A., Lowney L.I., Pal B.K. Stereospecific and nonspecific interactions of the morphine congener lecorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. U.S.A. 1971, 68:1742-1747.
11. Ingolia N.A., Dole V.P. Localization of d- and l-methadone after intraventricular injection into rat brains. J. Pharmacol. Exp. Ther. 1970, 13:84-87.
12. Kieffer B.L., Befort K., Gaveriaux-Ruff C., Hirth C.G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:12048-12052.
13. Kreek M.J., Bart G., Lilly C., LaForge K.S., Nielsen D.A. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol. Rev. 2005, 57:1-26.
14. Kreek M.J., LaForge K.S. Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene. Mol. Interv. 2007, 7:74-78.
15. Kreek M.J. Role of a functional human gene polymorphism in stress responsivity and addictions. Clin. Pharmacol. Ther. 2008, 83:615-618.
16. Kroslak T., LaForge K.S., Gianotti R.J., Ho A., Nielsen D.A., Kreek M.J. The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J. Neurochem. 2007, 103:77-87.
17. LaForge K.S., Yuferov V., Kreek M.J. Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur. J. Pharmacol. 2000, 410:249-268.
18. Levran O., Londono D., O'Hara K., Nielsen D.A., Peles E., Rotrosen J., Casadonte P., Linzy S., Randesi M., Ott J., Adelson M., Kreek M.J. Genetic susceptibility to heroin addiction: a candidate-gene association study. Genes Brain Behav. 2008, 7:720-729.
19. Mague S.D., Isiegas C., Huang P., Liu-Chen L.Y., Lerman C., Blendy J.A. Mouse model of OPRM1 (A119G) polymorphism has sex-specific effects on drug-mediated behavior. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:10847-10852.
20. Mague S.D., Blendy J.A. OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models. Drug Alcohol Depend 2010, 108:172-182.
21. Nielsen D.A., Ji F., Yuferov V., Ho A., Chen A., Levran O., Ott J., Kreek M.J. Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Mol. Psychiatry 2008, 13:417-428.
22. Pert C.B., Snyder S.H. Opiate receptor: demonstration in nervous tissue. Science (Wash. DC) 1973, 179:1011-1014.
23. 3H]etorphine to rat-brain homogenate. Proc. Natl. Acad. Sci. U.S.A. 1973, 70:1947-1949.
24. Terenius L. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacol. Toxicol. 1973, 32:317-320.
25. Trigo J.M., Martin-Garcia E.B., Robledo P., Maldonado R. The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend. 2010, 108:183-194.
26. Von Zastrow M. Regulation of opioid receptors by endocytic membrane traffic: Mechanisms and translational implications. Drug Alcohol Depend 2010, 108:166-171.
27. Zhang Y., Landthaler M., Schlussman S.D., Yuferov V., Ho A., Tuschl T., Kreek M.J. Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin. Neuroscience 2009, 158:474-483.
28. Zhang Y., Wang D., Johnson A.D., Papp A.C., Sadee W. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J. Biol. Chem. 2005, 280:32618-32624.